Search results
Narcolepsy an Independent Cardiovascular Disease Risk Factor
Medscape· 15 hours agoNarcolepsy is associated with an increased risk for CVD, independent of common comorbid conditions and medications used to treat the disorder, new research showed.
Studies show narcolepsy is a risk factor for cardiovascular disease and adverse cardiac events
Medical Xpress· 4 days agoResults show that people who have narcolepsy, compared with those without narcolepsy, had a 77% increased risk of any cardiovascular disease and an 82% ...
'Transformative': Novel Drug for Narcolepsy Effective in Mid-Stage Trial
MedPage Today· 3 days agoUnlike its predecessor, TAK-861 did not result in any hepatotoxicity or serious adverse events
Rx drug shortages hit all-time high, affecting prices
FOX 59 Indianapolis· 3 days agoINDIANAPOLIS – Across the nation, consumers are dealing with the effects of prescription drug...
Nearly 250 drugs are in short supply and causing a spike in prices
Consumer Affairs· 4 days agoAre we entering a new era of supply shortages? In addition to new reports that orange juice is in short supply, drugs – the stuff many of us use OJ to wash down – are also taking a major hit ...
Will Idiopathic Hypersomnia Ever Go Away?
Healthline· 4 days agoThere’s no cure for this condition that causes excessive daytime sleepiness. “Hypersomnia” refers to excessive daytime sleepiness. Much of the general...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days agoHARMONY BIOSCIENCES PRESENTS POSITIVE DATA FOR PITOLISANT IN THE TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS AND FATIGUE IN MYOTONIC DYSTROPHY TYPE 1 Phase 2 signal detection study presented at the annual meeting of the Associated Professional Sleep
Is Oversleeping Bad? Potential Causes and Side Effects (Including Weight Gain)
MediaFeed via AOL· 4 days agoSome of the reasons people sleep more than usual include: Depression and other mental health issues ...
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Average Rating of “Moderate Buy” from Analysts
ETF DAILY NEWS· 4 days agoShares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) have earned an average recommendation of “Moderate Buy” from the thirteen brokerages that are covering the firm, Marketbeat ...
